Neural network models have transformed many areas of life sciences, including protein structure prediction and molecular generation. However, due to limited high-quality data, purely data-driven AI models often lack the generalizability required to reliably model protein–ligand interactions, as recently demonstrated by our group ().
Our research therefore focuses on advancing next-generation drug design methodologies by integrating physicochemical principles directly into deep neural network approaches. Representative publications from our group include :
https : / / doi.org / 10.1021 / acs.jcim.2c01436
https : / / doi.org / 10.1021 / acs.jcim.1c01438
https : / / icml-compbio.github.io / 2023 / papers / WCBICML2023_paper159.pdf
https : / / doi.org / 10.1038 / s42004-020-0261-x
A fully funded PhD position is available in the Computational Pharmacy group at the University of Basel. The successful candidate will contribute to ongoing research on the development of novel physics-guided AI algorithms for drug design, integrating physics-based modeling with state-of-the-art deep learning methods. The project will focus on creating a next-generation docking framework that explicitly incorporates protein–ligand dynamics.
You will be responsible for :
Application /
Phd Position • Basel, Switzerland